Rasagiline NDC 42571-220

NDC codes

FDA NDC Directory

Product NDC (as listed)42571-220Labeler and product segments. Claims need a package NDC.

Product NDC at billing width42571-0220Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
42571-220-05	42571022005	500 TABLET in 1 BOTTLE (42571-220-05)Marketed from Apr 3, 2019
42571-220-10	42571022010	1000 TABLET in 1 BOTTLE (42571-220-10)Marketed from Apr 3, 2019
42571-220-30	42571022030	30 TABLET in 1 BOTTLE (42571-220-30)Marketed from Apr 3, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Rasagiline
Generic name (nonproprietary): rasagiline
Active ingredients: Rasagiline mesylate — .5 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Micro Labs Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 207004
Marketing start: Apr 3, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Monoamine Oxidase Inhibitors (Mechanism)
Identifiers: Product ID 42571-220_362d24c1-c384-4543-e063-6294a90a6b8fSPL ID 362d24c1-c384-4543-e063-6294a90a6b8fSPL set ID 42f8d62f-2c57-47bc-92e7-b28111aa8cd1RxCUI 608328, 636664UNII LH8C2JI290UPC 0342571220303, 0342571221300
Pharmacologic class: Monoamine Oxidase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N442571022005 followed by a unit qualifier and the quantity

Package 42571-0220-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 28, 2025.

Indications (excerpt from the label)

1. INDICATIONS AND USAGE Rasagiline tablets are indicated for the treatment of Parkinson's disease (PD). Rasagiline tablets are monoamine oxidase (MAO)-B inhibitor (MAOI), is indicated for the treatment of Parkinson's disease ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)